mechlorethamine has been researched along with Peripheral Nerve Diseases in 3 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bakemeier, RF | 1 |
Anderson, JR | 1 |
Costello, W | 1 |
Rosner, G | 1 |
Horton, J | 1 |
Glick, JH | 1 |
Hines, JD | 1 |
Berard, CW | 1 |
DeVita, VT | 1 |
Sagar, HJ | 1 |
Read, DJ | 1 |
Maslovsky, I | 1 |
Volchek, L | 1 |
Blumental, R | 1 |
Ducach, A | 1 |
Lugassy, G | 1 |
1 trial available for mechlorethamine and Peripheral Nerve Diseases
Article | Year |
---|---|
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Clinical Trials | 1984 |
2 other studies available for mechlorethamine and Peripheral Nerve Diseases
Article | Year |
---|---|
Subacute sensory neuropathy with remission: an association with lymphoma.
Topics: Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Hypesthesia; Mechlorethamine; Middle Age | 1982 |
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy; | 2001 |